Plasma cytokine and angiogenic factors associated with prognosis and therapeutic response to sunitinib vs everolimus in advanced non-clear cell renal cell carcinoma.

Oncotarget · 2017 · PMC5522056 · PMID 28178674

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

did not reach statistical significancep=0.057so close (0.05 < p ≤ 0.1)

A similar trend was seen when comparing patients with three elevated CAFs vs those with 2, although it did not reach statistical significance (HR = 2.9; 95% CI: 0.97-8.5; p=0.057).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.